Literature DB >> 34472017

Evidence-based clinical prioritization of embryos with mosaic results: a systematic review and meta-analysis.

Ali Mourad1, Roland Antaki1,2, François Bissonnette1,2, Obey Al Baini3, Boutros Saadeh4, Wael Jamal5,6.   

Abstract

PURPOSE: The purpose of this review and meta-analysis is to standardize the practice of mosaic embryo transfer, based on the current available evidence.
METHODS: This is a systematic review and meta-analysis. Relevant studies published were comprehensively selected using PubMed, Medline, Embase, and CENTRAL until 5 March 2021. Prospective and retrospective studies reporting the genetic analysis and clinical outcomes of mosaic embryo transfer were included. Risk of bias assessment was based on the Newcastle-Ottawa scale for the non-randomized studies. The primary and secondary outcomes were combined ongoing pregnancy and live birth rate and miscarriage rate, respectively.
RESULTS: There were no differences between low and high mosaic embryos when a cut-off of 40% was used in terms of OP/LBR and SAB. However, low mosaics with a cut-off of 50% compared to high mosaics showed a significantly higher OP/LBR in the NGS but not in the a-CGH group, and a significantly lower risk of SAB. No differences were noted between mosaic monosomies versus trisomies and single versus double mosaics for both OP/LBR and SAB. Finally, segmental mosaics showed a higher OP/LBR and a lower SAB compared to whole chromosomes, and single and double mosaics had a higher OP/LBR compared to complex mosaics.
CONCLUSIONS: A cut-off of 50% in defining low versus high mosaic embryos is preferable to a threshold of 40% when using NGS platform. No priority was established for mosaic trisomies over monosomies. Single and double mosaics must be preferred over complex mosaics and segmental mosaics must be preferred over whole chromosome mosaics. These results should be interpreted in the context of specific chromosomes involved in the mosaicism.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Assisted reproductive technology; In vitro fertilization; Mosaicism; Preimplantation genetic testing for aneuploidy (PGT-A)

Mesh:

Year:  2021        PMID: 34472017      PMCID: PMC8609000          DOI: 10.1007/s10815-021-02279-x

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  48 in total

1.  Implantation potential of mosaic embryos.

Authors:  Belén Lledó; Ruth Morales; Jose Antonio Ortiz; Helena Blanca; Jorge Ten; Joaquín Llácer; Rafael Bernabeu
Journal:  Syst Biol Reprod Med       Date:  2017-03-17       Impact factor: 3.061

2.  Many mosaic mutations.

Authors:  W D Foulkes; F X Real
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677

3.  The European collaborative study on mosaicism in chorionic villus sampling: data from 1986 to 1987.

Authors:  L O Vejerslev; M Mikkelsen
Journal:  Prenat Diagn       Date:  1989-08       Impact factor: 3.050

Review 4.  Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion.

Authors: 
Journal:  Fertil Steril       Date:  2020-08       Impact factor: 7.329

5.  Cytogenetic analysis of 2928 CVS samples and 1075 amniocenteses from randomized studies.

Authors:  S Smidt-Jensen; A M Lind; M Permin; J M Zachary; C Lundsteen; J Philip
Journal:  Prenat Diagn       Date:  1993-08       Impact factor: 3.050

6.  Medical Research Council European trial of chorion villus sampling. MRC working party on the evaluation pf chorion villus sampling.

Authors: 
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

7.  Why do euploid embryos miscarry? A case-control study comparing the rate of aneuploidy within presumed euploid embryos that resulted in miscarriage or live birth using next-generation sequencing.

Authors:  Susan M Maxwell; Pere Colls; Brooke Hodes-Wertz; David H McCulloh; Caroline McCaffrey; Dagan Wells; Santiago Munné; James A Grifo
Journal:  Fertil Steril       Date:  2016-09-28       Impact factor: 7.329

8.  Comprehensive molecular cytogenetic analysis of the human blastocyst stage.

Authors:  E Fragouli; M Lenzi; R Ross; M Katz-Jaffe; W B Schoolcraft; D Wells
Journal:  Hum Reprod       Date:  2008-07-29       Impact factor: 6.918

9.  Confined placental mosaicism, IUGR, and adverse pregnancy outcome: a controlled retrospective U.K. collaborative survey.

Authors:  J Wolstenholme; D E Rooney; E V Davison
Journal:  Prenat Diagn       Date:  1994-05       Impact factor: 3.050

10.  Identification of mosaic and segmental aneuploidies by next-generation sequencing in preimplantation genetic screening can improve clinical outcomes compared to array-comparative genomic hybridization.

Authors:  Hsing-Hua Lai; Tzu-Hsuan Chuang; Lin-Kin Wong; Meng-Ju Lee; Chia-Lin Hsieh; Huai-Lin Wang; Shee-Uan Chen
Journal:  Mol Cytogenet       Date:  2017-04-26       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.